Public filings / TNGX on Yahoo Finance (opens in a new tab)
TNGX: insider buying, 13F holders, analyst moves
Tango Therapeutics, Inc.
A summary of public filings about Tango Therapeutics, Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
7 of our 100 managers hold TNGX
Combined reported value $1.22B.
Holders among our 100 managers: 5 in Q3 2023, 7 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $434.5M | 3.71% | Added |
| Farallon Capital | $383.8M | 2.25% | Added |
| Deep Track Capital | $131.3M | 1.93% | Added |
| Deerfield Company | $131.0M | 1.37% | Added |
| Perceptive Advisors | $105.6M | 1.64% | Added |
| Samlyn Capital | $24.0M | 0.40% | New |
| Baker Bros. Advisors | $10.4M | 0.05% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.